Skip to main content

Advertisement

Table 1 Demographics and Baseline Characteristics (intent-to-treat population)

From: Combined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomised, controlled trial

Demographics (N = 52a)
Age, mean (SD) 35.4 (8.63)
Female, % 35
BMI, kg/m 2 , mean (range) 25.94 (18.9–33.6)
White race, % 92
Lung function
Pre-bronchodilator FEV 1 , L, mean (SD) 3.52 (0.713)
Pre-bronchodilator FEV 1 % Pred., mean (SD) 89.71 (8.848)
  1. a51 subjects took part in each of the treatment periods. BMI = body mass index; FEV1 = forced expiratory volume in 1 s; L = litres; SD = standard deviation.